X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8362) 8362
Newsletter (664) 664
Publication (656) 656
Newspaper Article (198) 198
Book Review (195) 195
Magazine Article (55) 55
Transcript (51) 51
Book / eBook (24) 24
Trade Publication Article (10) 10
Book Chapter (7) 7
Conference Proceeding (5) 5
Dissertation (5) 5
Data Set (3) 3
Reference (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7278) 7278
female (4385) 4385
arthritis, rheumatoid - drug therapy (4366) 4366
rheumatology (4125) 4125
rheumatoid arthritis (4089) 4089
index medicus (4020) 4020
antirheumatic agents - therapeutic use (3994) 3994
male (3993) 3993
antirheumatic agents - administration & dosage (3569) 3569
middle aged (3425) 3425
adult (2778) 2778
treatment outcome (2705) 2705
antirheumatic agents - adverse effects (2482) 2482
antirheumatic agents (2227) 2227
aged (2205) 2205
methotrexate (1834) 1834
arthritis (1662) 1662
drug therapy (1586) 1586
rheumatoid factor (1572) 1572
care and treatment (1484) 1484
infliximab (1380) 1380
drug therapy, combination (1363) 1363
tumor necrosis factor-alpha - antagonists & inhibitors (1321) 1321
double-blind (1262) 1262
etanercept (1228) 1228
therapy (1221) 1221
dosage and administration (1175) 1175
methotrexate - administration & dosage (1173) 1173
rheumatoid-arthritis (1131) 1131
research (1120) 1120
methotrexate - therapeutic use (1103) 1103
severity of illness index (989) 989
antibodies, monoclonal - therapeutic use (910) 910
disease (871) 871
pharmacology & pharmacy (843) 843
efficacy (815) 815
drug administration schedule (804) 804
animals (801) 801
dose-response relationship, drug (754) 754
adalimumab (752) 752
risk factors (735) 735
antibodies, monoclonal - administration & dosage (693) 693
safety (655) 655
time factors (633) 633
arthritis, rheumatoid - immunology (617) 617
modifying antirheumatic drugs (610) 610
methotrexate - adverse effects (607) 607
double-blind method (605) 605
health aspects (602) 602
antirheumatic agents - pharmacology (601) 601
adolescent (600) 600
analysis (596) 596
immunology (591) 591
tumor necrosis factor-tnf (585) 585
patients (567) 567
retrospective studies (564) 564
inflammation (563) 563
clinical trials (560) 560
antibodies, monoclonal - adverse effects (557) 557
follow-up studies (547) 547
studies (546) 546
drugs (535) 535
medicine, general & internal (529) 529
medicine & public health (510) 510
pharmaceutical industry (500) 500
arthritis, rheumatoid - diagnosis (492) 492
medical research (488) 488
abridged index medicus (483) 483
usage (473) 473
tumor necrosis factor (467) 467
disease-activity (449) 449
rituximab (447) 447
trial (430) 430
drug dosages (428) 428
prospective studies (428) 428
receptors, tumor necrosis factor - therapeutic use (428) 428
young adult (428) 428
immunoglobulin g - therapeutic use (426) 426
placebo-controlled trial (426) 426
disease progression (423) 423
complications and side effects (419) 419
arthritis, rheumatoid - physiopathology (415) 415
medicine, experimental (411) 411
musculoskeletal diseases (411) 411
research article (403) 403
arthritis, rheumatoid - complications (401) 401
child (396) 396
remission induction (392) 392
cytokines (387) 387
aged, 80 and over (382) 382
arthritis, rheumatoid - blood (365) 365
internal medicine (365) 365
arthritis, psoriatic - drug therapy (364) 364
patient outcomes (359) 359
receptors, tumor necrosis factor - administration & dosage (349) 349
antirheumatic agents - pharmacokinetics (346) 346
administration, oral (345) 345
immunoglobulin g - administration & dosage (342) 342
diagnosis (337) 337
antibodies, monoclonal, humanized (327) 327
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8657) 8657
German (252) 252
Japanese (132) 132
French (71) 71
Russian (60) 60
Spanish (43) 43
Italian (38) 38
Danish (18) 18
Polish (15) 15
Chinese (11) 11
Swedish (11) 11
Dutch (10) 10
Hungarian (8) 8
Norwegian (7) 7
Portuguese (5) 5
Czech (4) 4
Romanian (4) 4
Croatian (3) 3
Finnish (3) 3
Hebrew (3) 3
Korean (2) 2
Turkish (2) 2
Ukrainian (2) 2
Icelandic (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2014, Volume 73, Issue 4, pp. 710 - 715
Objective Compare the radiographic progression of ankylosing spondylitis (AS) patients treated with infliximab (INF) versus historical controls (Herne cohort,... 
RADIOGRAPHIC PROGRESSION | NECROSIS-FACTOR | ASAS RECOMMENDATIONS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | INFLAMMATION | DOUBLE-BLIND | RESONANCE-IMAGING PREDICT | RHEUMATOLOGY | INFLIXIMAB | AXIAL SPONDYLOARTHRITIS | CLINICAL-RESPONSE | Single-Blind Method | Follow-Up Studies | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Infliximab | Adult | Female | Retrospective Studies | Antirheumatic Agents - pharmacology | Cervical Vertebrae - physiopathology | Lumbar Vertebrae - physiopathology | Antirheumatic Agents - therapeutic use | Cervical Vertebrae - diagnostic imaging | Drug Administration Schedule | Lumbar Vertebrae - diagnostic imaging | Antibodies, Monoclonal - pharmacology | Osteogenesis - drug effects | Spondylitis, Ankylosing - drug therapy | Treatment Outcome | Spondylitis, Ankylosing - physiopathology | Disease Progression | Spondylitis, Ankylosing - diagnostic imaging | Radiography | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Observer Variation | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Usage | Dosage and administration | Tumor necrosis factor inhibitors | Ankylosing spondylitis | Tumor necrosis factor-TNF | Hypotheses | Inflammation | Patients | Colleges & universities
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2014, Volume 370, Issue 25, pp. 2377 - 2386
In patients with rheumatoid arthritis, tofacitinib was associated with greater reductions in signs and symptoms than methotrexate. Herpes zoster infections and... 
MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | ADALIMUMAB | RECOMMENDATIONS | COMBINATION THERAPY | JOINT DAMAGE | DISEASE | PLUS METHOTREXATE | DOUBLE-BLIND | ETANERCEPT | CP-690,550 | Herpes Zoster - etiology | Antirheumatic Agents - administration & dosage | Arthritis, Rheumatoid - blood | Cholesterol - blood | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Arthritis, Rheumatoid - complications | Dose-Response Relationship, Drug | Janus Kinase 3 - antagonists & inhibitors | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Piperidines - administration & dosage | Double-Blind Method | Administration, Oral | Pyrimidines - administration & dosage | Methotrexate - adverse effects | Protein Kinase Inhibitors - administration & dosage | Piperidines - adverse effects | Pyrimidines - adverse effects | Creatinine - blood | Methotrexate - administration & dosage | Care and treatment | Dosage and administration | Tofacitinib | Comparative analysis | Methotrexate | Rheumatoid arthritis | Creatinine | Herpes zoster | C-reactive protein | Kinases | Joint diseases | E.S.R | Lymphoma | Sedimentation | Cholesterol | Pain | Rheumatism | Janus kinase | Drug therapy | Pharmaceuticals | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9999, pp. 1137 - 1146
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2015, Volume 74, Issue 2, pp. 333 - 340
Journal Article
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 2014, Volume 41, Issue 5, pp. 837 - 852
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 508 - 519
In this trial of patients with rheumatoid arthritis who were on stable doses of methotrexate, tofacitinib, a novel oral Janus kinase inhibitor, was more... 
JAK INHIBITOR | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | RECOMMENDATIONS | CP-690,550 | Antirheumatic Agents - administration & dosage | Cholesterol - blood | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Janus Kinase 3 - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - administration & dosage | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Piperidines | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Leukocyte Count | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Enzyme Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Pyrimidines - administration & dosage | Neutrophils | Treatment Outcome | Lipoproteins - blood | Enzyme Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Least-Squares Analysis | Adalimumab | Arthritis, Rheumatoid - immunology | Drugs | Dose-response relationship (Biochemistry) | Tofacitinib | Rheumatoid arthritis | Dosage and administration | Product/Service Evaluations | Drug therapy | Comparative analysis | Studies | Tuberculosis | Monoclonal antibodies | Janus kinase | Methotrexate | Joint diseases | E.S.R | Sedimentation | Patients | Cholesterol
Journal Article
Journal Article